Neil Cashman - Sep 22, 2025 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Scientific Officer, Director
Signature
/s/ Max A. Milbury, Attorney in Fact for Neil Cashman
Stock symbol
PMN
Transactions as of
Sep 22, 2025
Transactions value $
$0
Form type
4
Date filed
9/24/2025, 08:51 AM
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cashman Neil Chief Scientific Officer, Director C/O PROMIS NEUROSCIENCES INC., SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, CANADA /s/ Max A. Milbury, Attorney in Fact for Neil Cashman 2025-09-24 0001927064

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +165K $0.00 165K Sep 22, 2025 Common Shares 165K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on September 1, 2026, and the balance shall vest ratably over 36 months